Newsroom

Gerresheimer AG

http://www.gerresheimer.com ISIN DE000A0LD6E6

Newsroom abonnieren

Abonnieren Sie alle Meldungen von Gerresheimer AG

11.10.2018 – 07:56

Gerresheimer AG

Gerresheimer increases revenues by 8.8% and successfully integrates Sensile Medical

Düsseldorf (ots) - - Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m - Adjusted EBITDA at constant exchange rates - excluding Sensile Medical and negative effects relating to the exemption from electricity network charges - increased by ...

11.10.2018 – 07:46

Gerresheimer AG

Andreas Schütte steps down from Management Board of Gerresheimer AG

Düsseldorf (ots) - Andreas Schütte (56) will step down from the Management Board of Gerresheimer AG at his own request as of February 28, 2019 in order to pursue new career challenges. The Supervisory Board of Gerresheimer AG approved this wish at its meeting yesterday. Andreas Schütte has served on the ...

27.09.2018 – 11:00

Gerresheimer AG

Micro pump for Parkinson's treatment from Gerresheimer subsidiary Sensile Medical receives European CE declaration of conformity

Duesseldorf/Olten (ots) - A wearable micro pump from Sensile Medical has received EU certification for the European market. A European pharma company has obtained a CE declaration of conformity for the pump, which is specially designed for the treatment of Parkinson's ...

06.09.2018 – 12:04

Gerresheimer AG

Dietmar Siemssen appointed new CEO of Gerresheimer AG

Duesseldorf (ots) - - Dietmar Siemssen to assume as Chief Executive Officer on November 1, 2018 - Previously held position as Stabilus CEO - Speaker of the Management Board and CFO Rainer Beaujean will not extend contract after April 30, 2019 Dietmar Siemssen (55) will join the Management Board of Gerresheimer AG as Chief Executive Officer on November 1, ...

11.07.2018 – 21:37

Gerresheimer AG

Gerresheimer extends business model and increases growth forecast

Düsseldorf (ots) - - With the acquisition of Sensile Medical, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers. The purchase price is a ...

12.04.2018 – 07:30

Gerresheimer AG

Gerresheimer raises earnings per share in first quarter due to US tax reform

Düsseldorf (ots) - - Revenues at constant exchange rates EUR 299.2m in first quarter of 2018, as expected, stable relative to prior-year period; organic revenue growth 0.4% - Adjusted EBITDA at constant exchange rates EUR 54.9m, as budgeted below the EUR 59.0m prior-year figure - Development of US dollar against ...

22.02.2018 – 07:30

Gerresheimer AG: Gerresheimer reports strong fourth quarter after difficult first nine months

4

Gerresheimer AG

Gerresheimer reports strong fourth quarter after difficult first nine months

05.02.2018 – 20:22

Gerresheimer AG

Dr. Christian Fischer resigns as CEO of Gerresheimer AG

Düsseldorf (ots) - Dr. Christian Fischer, Chairman of the Management Board of Gerresheimer AG, will leave the Company with immediate effect. Dr. Fischer has asked for an amicable premature termination of his services due to personal reasons. Such decision is not based on diverging views regarding the strategy or business performance of the Company. The Supervisory Board has accepted such request. The Company will be managed by the remaining three ...

23.01.2018 – 20:57

Gerresheimer AG

Gerresheimer expects significant positive effects from the US tax reform in 2018

Düsseldorf (ots) - On December 22, 2017, the US President signed the US tax reform, also known as the Tax Cuts and Jobs Act. The main changes from Gerresheimer's standpoint concern the reduction of the federal corporate tax rate from previously 35 % to now 21 % effective from January 1, 2018 and the elimination of certain previously available deductions from taxable income. There are also additional ...

Aktuelle Foto-Meldungen

Alle Meldungen mit Foto anzeigen

22.02.2018 – 07:30

Gerresheimer AG: Gerresheimer reports strong fourth quarter after difficult first nine months

4

Gerresheimer AG

Gerresheimer reports strong fourth quarter after difficult first nine months

08.01.2018 – 10:00

Gerresheimer AG: Dr. Lukas Burkhardt new member of the Management Board at Gerresheimer AG

1

Gerresheimer AG

Dr. Lukas Burkhardt new member of the Management Board at Gerresheimer AG

31.08.2017 – 10:00

Gerresheimer AG: Dr. Christian Fischer to succeed Uwe Röhrhoff as CEO of Gerresheimer AG

1

Gerresheimer AG

Dr. Christian Fischer to succeed Uwe Röhrhoff as CEO of Gerresheimer AG

08.01.2018 – 10:00

Gerresheimer AG: Dr. Lukas Burkhardt new member of the Management Board at Gerresheimer AG

1

Gerresheimer AG

Dr. Lukas Burkhardt new member of the Management Board at Gerresheimer AG

11.10.2017 – 07:30

Gerresheimer AG

Gerresheimer in Q3 2017: Slight improvement in adjusted EBITDA margin

Düsseldorf (ots) - - Revenues down from EUR 350.4m in Q3 2016 to EUR 331.5m in Q3 2017; organic decrease of 4.3%. Adjusted EBITDA margin slightly improved to 23.4% (Q3 2016: 23.2%) - EBITDA leverage, at 2.6, back at same level as of November 30, 2016 and thus significantly better than expected - Successful launch of EUR 250.0m promissory loan - Outlook: Company expects good Q4 2017. Nonetheless there are ...

31.08.2017 – 10:00

Gerresheimer AG: Dr. Christian Fischer to succeed Uwe Röhrhoff as CEO of Gerresheimer AG

1

Gerresheimer AG

Dr. Christian Fischer to succeed Uwe Röhrhoff as CEO of Gerresheimer AG

13.07.2017 – 07:30

Gerresheimer AG

Gerresheimer expecting recovery in second half year

Düsseldorf (ots) - - Revenues in second quarter of 2017 down 2.2% to EUR 339.5m as expected - Adjusted EBITDA margin 22.3%, versus 23.2% in prior-year quarter - Slight increase in Adjusted EBITDA leverage to 2.7 due to dividend payout and bond interest - More specific guidance for the financial year 2017 After a moderate second quarter, Gerresheimer AG ...

06.04.2017 – 07:30

Gerresheimer AG

Gerresheimer confirms guidance despite moderate start to the year

Duesseldorf (ots) - - Revenues down 5.4% in first quarter of 2017 to EUR 302.8m - Adjusted EBITDA margin at 19.8%, as in prior year - EBITDA leverage unchanged at 2.6 - Guidance for financial year 2017 confirmed, with consolidated revenues initially at lower end of range Gerresheimer AG made a moderate start to ...

15.02.2017 – 07:30

Gerresheimer AG

Gerresheimer delivers sustained profitability growth in 2016 and proposes a dividend increase of 23.5%

Düsseldorf (ots) - - Proposed dividend of EUR 1.05 per share (2015: EUR 0.85 per share) marks an increase of 23.5% - Revenues up 7.2% in financial year 2016 to EUR 1,375.5m - Revenues at constant exchange rates EUR 1,383.1m with 2.9% organic revenue growth - Adjusted EBITDA ...

12.09.2016 – 08:00

Gerresheimer AG

Gerresheimer to sell Life Science Research business

Düsseldorf (ots) - - Gerresheimer and Chase Scientific Glass, Inc. are to sell their joint venture (51/49%) Kimble Chase to Duran Group, a portfolio company of One Equity Partners - Total transaction enterprise value of USD 131m for 100% of the business In line with its strategy of focusing on packaging and device solutions for pharmaceutical customers, ...

07.07.2016 – 07:30

Gerresheimer AG

Gerresheimer substantially increases earnings in second quarter

Duesseldorf (ots) - - Revenues up 4.0% to EUR 370.5m - Adjusted EBITDA rises 17.5% to EUR 84.7m - Adjusted EBITDA margin climbs to 22.8% - Adjusted earnings per share surpass prior-year quarter by 34.5% to reach EUR 1.13 Gerresheimer AG, one of the leading partners to the pharma and healthcare industry worldwide, ...

13.04.2016 – 07:30

Gerresheimer AG

Gerresheimer reports strong first quarter

Düsseldorf (ots) - - First quarter revenues up 13.4% to EUR 342.3m - Adjusted EBITDA grows by 29.6% to EUR 66.0m (Q1 2015: EUR 51.0m) - Adjusted earnings per share surpasses prior year quarter by 72.1% to reach EUR 0.74 - Guidance for financial year 2016 confirmed Gerresheimer AG, one of the leading partners to the pharma and healthcare industry worldwide, ...

Das Neueste via Twitter

twitter.com/Gerresheimer

11.02.2016 – 07:30

Gerresheimer AG

Gerresheimer expects around 9% growth in 2016

Duesseldorf (ots) - - Revenues in financial year 2015 up 6.8% to EUR 1,377.2m - Adjusted EBITDA climbs to EUR 277.9m - Adjusted earnings per share rise 18.0% to EUR 3.41 - Proposed dividend of EUR 0.85 per share (2014: EUR 0.75 per share) - Centor acquisition, sale of glass tubing business and refinancing successfully completed - Approximately 9% revenue ...

08.10.2015 – 07:30

Gerresheimer AG

Gerresheimer reports good third quarter - Centor acquisition completed

Duesseldorf (ots) - - Revenues up 6.2% to EUR 344.0m, 3.1% on organic basis - Adjusted EBITDA rises 9.5% to EUR 68.0m - Adjusted net income increases by 28.3% to EUR 29.2m - Adjusted earnings per share climb to EUR 0.85 - Operating cash flow up by EUR 58.6m to EUR 104.5m in Q1-Q3 - Guidance reiterated for financial ...

09.07.2015 – 07:30

Gerresheimer AG

Gerresheimer substantially improves operating earnings in second quarter

Duesseldorf (ots) - - Revenues up 6.3% to EUR 356.4m (1.9% on an organic basis) - Adjusted EBITDA rises 10.6% to EUR 72.1m - Net income grows by 7.4% to EUR 22.4m - Earnings per share lifted to EUR 0.65 - Guidance confirmed for financial year 2015 - Refinancing successfully completed Gerresheimer AG kept up its ...

14.04.2015 – 07:30

Gerresheimer AG

Gerresheimer raises earnings in first quarter

Duesseldorf (ots) - - Revenues up 1.4% to EUR 301.8m (organic growth -2.4%) - Adjusted EBITDA growth of 7.2% to EUR 51.0m (Q1 2014: EUR 47.6m) - Net income climbs 22.8% to EUR 12.7m (Q1 2014: EUR 10.3m) - Earnings per share up 20.7% on prior-year quarter, at EUR 0.35 - Guidance confirmed for 2015 - Cross reference: Press release including table is available ...

11.02.2015 – 07:30

Gerresheimer AG

Gerresheimer achieves all targets in 2014

Duesseldorf (ots) - - Revenues up 1.9% (3.7% organically) to EUR 1,290.0m - Adjusted EBITDA totals EUR 258.5m at constant exchange rates - Earnings per share up 6.6% to EUR 2.11 - Proposed dividend of EUR 0.75 per share (prior year: EUR 0.70 per share) - International expansion continues Gerresheimer AG, one of the leading partners to the pharma and ...

22.10.2014 – 11:00

Gerresheimer AG

Gerresheimer opens its first Development Center in China

Düsseldorf/Dongguan City (People's Republic of China) (ots) - Gerresheimer AG, an internationally leading partner to the pharma and healthcare industry, has opened a new Development Center for medical plastic systems in Dongguan City, China. Now Gerresheimer has three such centers in Wackersdorf (Germany), Peachtree City (United States of America) and now ...

08.10.2014 – 19:51

Gerresheimer AG

Gerresheimer expecting 4% to 6% revenue growth in medium term

Duesseldorf/Buende (ots) - - Gerresheimer sees good growth opportunities in long-term megatrends of pharma and healthcare - Growing importance of drug delivery and dosage devices in Western markets and of pharmaceutical primary packaging business in emerging markets - Mid-term growth potential 2016 to 2018: 4% to 6% ...

08.10.2014 – 07:30

Gerresheimer AG

Gerresheimer increases third-quarter revenues

Duesseldorf (ots) - - Revenues up 2.2% to EUR 323.9m (+3.2% at constant exchange rates) - Adjusted EBITDA with slight improvement on prior-year quarter at EUR 62.1m - Net income slightly over prior-year level at EUR 19.8m - Adjusted earnings per share exactly match prior-year quarter, at EUR 0.67 - Outlook for financial year 2014 made more specific ...

10.07.2014 – 07:30

Gerresheimer AG

Gerresheimer substantially increases earnings in second quarter

Duesseldorf (ots) - - Revenues up 2.6% to EUR 335.4m (6.0% at constant exchange rates) - Adjusted EBITDA rises 9.1% to EUR 65.1m (14.1% at constant exchange rates) - Net income grows by 70.3% to EUR 20.8m - EUR 0.61 earnings per share higher than prior-year quarter (Q2 2013: EUR 0.34) - Guidance for financial year ...

Das Neueste via Facebook

de-de.facebook.com/Gerresheimer.International

123Nächste